IP Library Granted Patent US 8,679,736
Granted Patent B2
US 8,679,736 · App. 12/640,878 · Granted Mar 25, 2014

Removal of adenine during a pathogen reduction process in whole blood or red blood cells by dilution

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,679,736
App. No.
12/640,878
Granted
Mar 25, 2014
Kind
B2
Abstract

The methods of this invention involve preventing the formation of a complex between adenine and riboflavin by reducing the amount of adenine in a solution containing blood or blood components to be pathogen reduced.

Claims (12)

1. A method for treating a quantity of platelets to reduce pathogens which may be present therein, the method comprising:

adding a volume of a washing solution to a fluid comprising: platelets and a platelet storage solution comprising adenine;

washing the fluid to remove adenine and create a washed fluid comprising the platelets;

adding a pathogen reduction-effective, non-toxic amount of 7,8-dimethyl-10-ribityl isoalloxazine photosensitizer to the washed fluid; and

reducing pathogens in the washed fluid by exposing the washed fluid containing the photosensitizer and the platelets to photoradiation of sufficient wavelength and energy to activate the photosensitizer.

2. A method for treating a quantity of red blood cells to reduce pathogens which may be present therein, the method comprising:

adding a volume of a washing solution to a fluid comprising: red blood cells and a red blood cell storage solution comprising adenine;

washing the fluid to remove adenine and create a washed fluid comprising the red blood cells;

adding a pathogen reduction-effective, non-toxic amount of 7,8-dimethyl-10-ribityl isoalloxazine photosensitizer to the washed fluid; and

reducing pathogens in the washed fluid by exposing the washed fluid containing the photosensitizer and the red blood cells to photoradiation of sufficient wavelength and energy to activate the photosensitizer.

3. The method of claim 2 wherein the washing further comprises a plurality of washing steps.

4. The method of claim 2 wherein the adding the pathogen reduction-effective, non-toxic amount of 7,8-dimethyl-10-ribityl isoalloxazine photosensitizer step, further comprises placing the washed fluid in a container transparent to photoradiation, adding the photosensitizer to the fluid in the container and agitating the container.

Assignments (4)
CHANGE OF NAME Recorded Feb 16, 2012
From: CARIDIANBCT BIOTECHNOLOGIES, LLC.
To: TERUMO BCT BIOTECHNOLOGIES, LLC
Reel/Frame 027715/0552 →
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2011
From: CITICORP TRUSTEE COMPANY LIMITED, AS SECURITY AGENT
To: CARIDIANBCT BIOTECHNOLOGIES, LLC
Reel/Frame 026192/0547 →
SECURITY AGREEMENT SUPPLEMENT Recorded Jul 16, 2010
From: CARIDIANBCT BIOTECHNOLOGIES, LLC
To: CITICORP TRUSTEE COMPANY LIMITED, AS SECURITY AGENT
Reel/Frame 024686/0972 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2009
From: GOODRICH, RAYMOND P.; DOANE, SUZANN K.
To: CARIDIANBCT BIOTECHNOLOGIES, LLC
Reel/Frame 023671/0791 →